WebAbout us: Highwire Public Relations is a modern communications agency designed for disruptive companies. As the top-ranked independent tech and healthcare PR firm, we represent some of the biggest brands in cloud, enterprise, security, fintech, healthcare, and consumer. We are nimble, creative and committed to growth and inclusivity for all our ... WebAbout us: Highwire Public Relations is a modern communications agency designed for disruptive companies. As the top-ranked independent tech and healthcare PR firm, we represent some of the biggest ...
The HighWire - Home
WebMar 28, 2024 · Highwire is backed by global growth equity investor Summit Partners. The company is headquartered in Burlington, Massachusetts , with employees across the United States . For more information ... WebHighWire, welcome to the MPS family Frequently Asked Questions MPS successfully completed the acquisition of HighWire Press on July 1, 2024. Both MPS and HighWire share a passion for solving complex problems through technology and innovation with an immense focus on customer satisfaction. incidence of anemia
Characterising the autoantibody repertoire in systemic sclerosis ...
WebApr 9, 2024 · The Crowd Resilience Tour has made its way to the US, bringing together a diverse group of thought leaders in the medical freedom movement, including musicians, doctors, scientists, and other experts. ... Following The HighWire’s exposé spotlighting the large role WHO Chief Scientist Jeremy Farrar had in suppressing the lab origin debate in ... WebBuilding brands leading into the future. Whatever lies ahead for you, Highwire turns milestones into momentum. LEARN MORE > You need something different We're ready to combine our expertise with your ambitions to help you reach a higher level. LET'S TALK > WebObjectives Results from the SCOT (Scleroderma: Cyclophosphamide Or Transplantation) clinical trial demonstrated significant benefits of haematopoietic stem cell transplant (HSCT) versus cyclophosphamide (CTX) in patients with systemic sclerosis. The objective of this study was to test the hypothesis that transplantation stabilises the autoantibody … inconclusive root cause